Volume 7,Issue 1
Clinical Observation and Impact on Quality of Life in the Treatment of Hypertensive Nephropathy with Jianshen Mixture
Objective: To analyze the effect of Jianshen Mixture in the treatment of hypertensive nephropathy, especially to explore its impact on patients’ quality of life. Methods: From April 2024 to March 2025, 68 patients with hypertensive nephropathy were selected for data analysis in our hospital. They were divided into groups by lottery, with 34 patients in each group. The experimental group was treated with conventional Western medicine treatment + Jianshen mixture, and the control group was treated with conventional Western medicine treatment. The data differences between the groups were compared. Results: Compared with the control group, the TCM syndrome scores of the experimental group were significantly lower after treatment, the total effective rate was significantly higher, blood pressure, blood β2-MG, and urine mALB levels were significantly lower after treatment, serum IL-6, hs-CRP, and TNF-α levels were significantly lower after treatment, and adverse reactions were The incidence rate was significantly lower, and the quality of life score after treatment was significantly higher, P < 0.05; comparing the TCM syndrome scores, blood pressure, blood β2-MG, urinary mALB, serum IL-6, hs-CRP, TNF-α levels, and quality of life scores before treatment between the two groups, P > 0.05. Conclusion: The application of Jianshen Mixture in the treatment of hypertensive nephropathy has ideal effects. It has higher treatment efficiency, a more significant antihypertensive effect and a possible protective effect on renal function. It can help patients stabilize their condition and improve their quality of life, and has high application value.
[1] Deng ZW, Yang BY, Peng YJ, et al., 2025, Meta-Analysis of the Efficacy of Liver-Calming Traditional Chinese Medicine Decoction Combined with Western Medicine in the Treatment of Hypertensive Nephropathy. Hunan Journal of Traditional Chinese Medicine, 41(7): 110–116.
[2] Wan CZ, Ma HB, Wei JH, et al., 2025, Case Studies on the Treatment of Hypertensive Nephropathy with Chaichen Zexie Decoction. Chinese Ethnic and Folk Medicine, 34(13): 100–103.
[3] Li X, Jing HX, 2025, Clinical Observation of Modified Danggui Buxue Decoction Combined with Irbesartan in the Treatment of Elderly Hypertensive Nephropathy. Chinese Folk Therapy, 33(13): 73–76.
[4] Zeng GH, 2025, Effect of the Combination of Danggui Buxue Decoction, Candesartan, and Fosinopril on Patients with Diabetic Nephropathy and Hypertension. Medical Theory and Practice, 38(5): 796–799.
[5] Ni C, Ming L, 2025, The Effect of Bushen Huoxue Decoction Combined with Conventional Antihypertensive Drugs in the Treatment of Elderly Hypertensive Nephropathy and Its Impact on CRP and Cys C Levels. Medical Frontiers, 15(7): 80–83.
[6] Zhu L, Zeng JB, 2025, Effects of Amlodipine Besylate Tablets Combined with Bushen Huoxue Decoction on Patients with Hypertensive Nephropathy. Chinese and Foreign Medical Research, 23(1): 54–57.
[7] Lin SF, Xiao Y, 2024, Based on Network Pharmacology and Molecular Docking to Explore the Mechanism of Action of Astragalus and Salvia Miltiorrhiza in the Treatment of Diabetic Nephropathy and Hypertensive Nephropathy by “Treating Different Diseases with the Same Treatment”. Chinese Hospital Drug Evaluation and Analysis, 24(12): 1429–1433 + 1439.
[8] Wang XQ, Wang GG, 2024, Exploring the Mechanism of Action of Yanggan Yishui Granules in the Treatment of Hypertensive Nephropathy Based on Network Pharmacology and Molecular Docking. Clinical Research in Traditional Chinese Medicine, 16(21): 51–59.